Xarelto is an anticoagulant that is prescribed for the treatment of atrial fibrillation, which is a condition that causes an irregular heartbeat and circulatory problems. It was marketed as an alternative to Warfarin and similar anticoagulants under the premise that patients would not need to undergo regular blood monitoring as those who take other anticoagulants must.
This claim, among several others made by Johnson and Johnson about the medication, was proven to be erroneous and misleading. Other claims about the effectiveness of the medication for the treatment of other medical conditions were also claimed to be incorrect and those prescribed with Xarelto experienced greater risk of internal bleeding or hemorrhaging than if they had been prescribed alternatives.
Rosenfeld Injury Lawyers is committed to protecting the legal rights of individuals and their families that have been harmed after taking Xarelto. Our law firm is actively investigating cases involving uncontrolled bleeding following Xarelto use. We invite you to contact our law firm where you can speak to an attorney about your situation and the status of lawsuits involving Xarelto. As with all of our pharmaceutical cases, there is never a fee charged unless there is a recovery for you.
False or Misleading Claims Relating To Effectiveness of Xarelto for Patients With Circulatory Issues
It is no surprise that medications designed to thin the blood may cause bleeding and that patients requiring their use should be monitored for the early detection of any complications or side effects. Johnson and Johnson’s assertion that monitoring and dosage adjustments would not be necessary was irresponsible and negligent. In addition, Johnson and Johnson failed to notify consumers of the following serious risks of taking Xarelto.
- Elevated risk of severe bleeds— some of which were unable to be stopped or treated.
- Increased risk of stroke or hemorrhaging in the brain.
- Risk of paralysis in patients receiving a spinal tap while taking Xarelto.
- The lack of an agent designed to reverse or stop bleeds in patients taking Xarelto.
- Increased risk of blood clot or stroke upon cessation of treatment.
Xarelto Proposed as a Treatment for Additional Medical Conditions Such as DVT and Pulmonary Embolism
Xarelto was initially only considered as a medicine for the treatment of atrial fibrillation but had since received approval to be used for the treatment of deep vein thrombosis and pulmonary embolisms. Patients prescribed Xarelto were unaware that there was no research or evidence available to support the claim that the medication was any more effective than alternatives such as Warfarin; which were later proven to be more effective and less expensive without the additional risks associated with Xarelto. Due to the numerous misleading claims made about its product, Johnson and Johnson may be liable for any injuries or deaths that resulted from the use of Xarelto.When to Speak with an Attorney at Rosenfeld Injury Lawyers to Discuss Your Xarelto Fatality Case
If you or a loved one suffered from a stroke, hemorrhage or bleeding while taking Xarelto, you may be entitled to compensation for medical treatment and pain and suffering that is associated with you or your loved one’s injuries. Contact Rosenfeld Injury Lawyers today to schedule a risk free consultation with one of our product liability attorneys to learn more about your rights and legal options.
We will be glad to review the details of your Xarelto case in a confidential evaluation and advise you on whether you have a claim and how best to proceed. Our lawyers work on a contingency basis, which means you will never be required to pay a fee upfront and if we are unable to earn compensation on your behalf, our services will be free of charge.